Literature DB >> 26923397

Mislocalization of neuronal tau in the absence of tangle pathology in phosphomutant tau knockin mice.

Jonathan Gilley1, Kunie Ando2, Anjan Seereeram3, Teresa Rodríguez-Martín3, Amy M Pooler3, Laura Sturdee4, Brian H Anderton3, Jean-Pierre Brion2, Diane P Hanger3, Michael P Coleman4.   

Abstract

Hyperphosphorylation and fibrillar aggregation of the microtubule-associated protein tau are key features of Alzheimer's disease and other tauopathies. To investigate the involvement of tau phosphorylation in the pathological process, we generated a pair of complementary phosphomutant tau knockin mouse lines. One exclusively expresses phosphomimetic tau with 18 glutamate substitutions at serine and/or threonine residues in the proline-rich and first microtubule-binding domains to model hyperphosphorylation, whereas its phosphodefective counterpart has matched alanine substitutions. Consistent with expected effects of genuine phosphorylation, association of the phosphomimetic tau with microtubules and neuronal membranes is severely disrupted in vivo, whereas the phosphodefective mutations have more limited or no effect. Surprisingly, however, age-related mislocalization of tau is evident in both lines, although redistribution appears more widespread and more pronounced in the phosphomimetic tau knockin. Despite these changes, we found no biochemical or immunohistological evidence of pathological tau aggregation in mice of either line up to at least 2 years of age. These findings raise important questions about the role of tau phosphorylation in driving pathology in human tauopathies.
Copyright © 2016 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hyperphosphorylation; Knockin mouse; Phosphodefective; Phosphomimetic; Tau; Tauopathy

Mesh:

Substances:

Year:  2015        PMID: 26923397     DOI: 10.1016/j.neurobiolaging.2015.11.028

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  9 in total

1.  Ectopic Expression Induces Abnormal Somatodendritic Distribution of Tau in the Mouse Brain.

Authors:  Atsuko Kubo; Shouyou Ueda; Ayaka Yamane; Satoko Wada-Kakuda; Mai Narita; Makoto Matsuyama; Akane Nomori; Akihiko Takashima; Taisuke Kato; Osamu Onodera; Motohito Goto; Mamoru Ito; Takami Tomiyama; Hiroshi Mori; Shigeo Murayama; Yasuo Ihara; Hiroaki Misonou; Tomohiro Miyasaka
Journal:  J Neurosci       Date:  2019-06-24       Impact factor: 6.167

Review 2.  The Role of the Carboxyl-Terminal Sequence of Tau and MAP2 in the Pathogenesis of Dementia.

Authors:  Ce Xie; Tomohiro Miyasaka
Journal:  Front Mol Neurosci       Date:  2016-12-27       Impact factor: 5.639

Review 3.  What is the evidence that tau pathology spreads through prion-like propagation?

Authors:  Amrit Mudher; Morvane Colin; Simon Dujardin; Miguel Medina; Ilse Dewachter; Seyedeh Maryam Alavi Naini; Eva-Maria Mandelkow; Eckhard Mandelkow; Luc Buée; Michel Goedert; Jean-Pierre Brion
Journal:  Acta Neuropathol Commun       Date:  2017-12-19       Impact factor: 7.801

4.  Tau Ser208 phosphorylation promotes aggregation and reveals neuropathologic diversity in Alzheimer's disease and other tauopathies.

Authors:  Yuxing Xia; Stefan Prokop; Kimberly-Marie M Gorion; Justin D Kim; Zachary A Sorrentino; Brach M Bell; Alyssa N Manaois; Paramita Chakrabarty; Peter Davies; Benoit I Giasson
Journal:  Acta Neuropathol Commun       Date:  2020-06-22       Impact factor: 7.801

Review 5.  Alzheimer's Disease and Type 2 Diabetes: A Critical Assessment of the Shared Pathological Traits.

Authors:  Shreyasi Chatterjee; Amritpal Mudher
Journal:  Front Neurosci       Date:  2018-06-08       Impact factor: 4.677

6.  An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.

Authors:  Abhinaba Ghosh; Sarah E Torraville; Bandhan Mukherjee; Susan G Walling; Gerard M Martin; Carolyn W Harley; Qi Yuan
Journal:  Alzheimers Res Ther       Date:  2019-07-03       Impact factor: 6.982

Review 7.  Cellular Biology of Tau Diversity and Pathogenic Conformers.

Authors:  Sang-Gyun Kang; Ghazaleh Eskandari-Sedighi; Lenka Hromadkova; Jiri G Safar; David Westaway
Journal:  Front Neurol       Date:  2020-11-12       Impact factor: 4.003

Review 8.  Amyloidosis in Alzheimer's Disease: Pathogeny, Etiology, and Related Therapeutic Directions.

Authors:  Chen Ma; Fenfang Hong; Shulong Yang
Journal:  Molecules       Date:  2022-02-11       Impact factor: 4.411

Review 9.  "Don't Phos Over Tau": recent developments in clinical biomarkers and therapies targeting tau phosphorylation in Alzheimer's disease and other tauopathies.

Authors:  Yuxing Xia; Stefan Prokop; Benoit I Giasson
Journal:  Mol Neurodegener       Date:  2021-06-05       Impact factor: 14.195

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.